Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma

ConclusionsPV therapy may be a relatively safe treatment method for DLBCL patients on HD.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research